1. 2020
  2. Treatment Eligibility of Real-Life Mepolizumab-Treated Severe Asthma Patients

    Richards, L. B., van Bragt, J. J. M. H., Aarab, R., Longo, C., Neerincx, A. H., Sont, J. K., Weersink, E. J. M., Braunstahl, G-J., Brinke, A. T., Bel, E. H. D. & Maitland-van der Zee, A-H., Oct 2020, In: Journal of Allergy and Clinical Immunology: In Practice. 8, 9, p. 2999-3008.e1

    Research output: Contribution to journalArticleAcademicpeer-review

  3. 2019
  4. Prevalence of and factors associated with adult-onset asthma in different ethnic groups: The HELIUS study

    Aarab, R., Vijverberg, S. J. H., Prins, M., Snijder, M. B., van Ree, R., Fokkens, W. J., Zwinderman, A. H., Bel, E. H. D. & Maitland van der Zee, A. H., 2019, In: Respiratory medicine. 150, p. 113-119

    Research output: Contribution to journalArticleAcademicpeer-review

  5. 2013
  6. Monitoring of unfractionated heparin in critically ill patients

    Aarab, R., van Es, J., de Pont, A. C. J. M., Vroom, M. B. & Middeldorp, S., 2013, In: Netherlands journal of medicine. 71, 9, p. 466-471

    Research output: Contribution to journalReview articleAcademicpeer-review

ID: 114240